The Asia-Pacific Peptide Therapeutics Market will see a considerable growth of 6.7% during the forecast period. Asia-Pacific is one of the promising regions in the field of peptides. The frequent collaboration of various global and domestic companies through workshops and seminars is also expected to present a new growth opportunity for the Asia-Pacific Peptide Therapeutics Market.
‘AsiaTIDES Oligonucleotide & Peptide Therapeutics’ is expected to take place between November 11 to 13, 2020. It is the only event in Asia that is expected to bring together science, technologies, and partners to accelerate oligonucleotide and peptide molecules to market. It offers separate tracks covering the latest oligonucleotide and peptide development strategies from discovery, nonclinical, clinical, and CMC to late-stage development and commercialization.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-peptide-therapeutics-market
- Drug delivery of oligonucleotides, peptides, mRNA, RNA, and CRISPR
- CMC approaches to accelerate peptide, oligonucleotides, and mRNA therapeutics
- The future of peptide vaccines and personalized peptide therapies
Additionally, numerous global companies are also expanding their R&D centers across the region which will also aid the growing shares of the Peptide Therapeutics Market in Asia-Pacific. The global market
players are expanding their reach in the emerging economies of the region, especially in India, China, Vietnam, and Indonesia. With this expansion, the market for peptide therapeutics is expected to increase in Asia-Pacific during the forecast period.
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Route of Administration and By Application
- Countries Covered- China, Japan, India, Rest of Asia-Pacific
- Key Companies Profiled- Novo Nordisk A/S, Eli Lilly & Co., Amgen Inc., Astellas Pharma Inc., Teva Pharmaceuticals Industries Ltd., and Takeda Pharmaceutical Co. Ltd.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Asia-Pacific Peptide Therapeutics Market – Segmentation
By Route of Administration
- Oral
- Parenteral
By Application
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others
A full report of Asia-Pacific Peptide Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-peptide-therapeutics-market
Asia-Pacific Peptide Therapeutics Market – Segment by Region
- China
- Japan
- India
- Rest of Asia-Pacific
Company Profiles
- Amgen, Inc.
- Astellas Pharma Inc.
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Novartis International AG
- Novo Nordisk A/S
- Simcere Pharmaceutical Group
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Qingdao Primedicine Pharmaceutical Co. Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
